A number of issues discussed on the call and I highlighted what for me was important.
1) They have 35MM in cash 12/31/2011 that is sufficient for the next 12 months.
2) Meeting with Pfizer management team to plan response strategy.
3) No additional clinical studies requested.
4) Manufacturing plant given FDA acceptance /approval.
5) Have data that FDA is requesting but needs clarification.
6) European Approval (EMA) on schedule April 2011
7) FDA turn around time 2-6 months (estimated until meeting with them)
8) PLX management team confident of approval in 2011.
Share This Post:
I like to scalp, day trade and swing trade. My posts are my opinion only.Do your own research and due diligence . You could lose all your investment following my trades. Never trade with more then you can afford to lose. I'm not an investment advisor.